Document:

Exhibit

Exhibit 4.1

 
 

Second Supplemental Indenture
Dated as of March 9, 2016

Supplement to the Senior Indenture
 Dated as of September 10, 2010
 
EDISON INTERNATIONAL

 Issuer

and

THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.

 Trustee
 
 
 

 

 
	
				
	TABLE OF CONTENTS

	 
	 
	 
	 

	 
	 
	 
	 

	 
	 
	 
	 

	RECITALS OF THE CORPORATION
	1

	ARTICLE I
	DEFINITIONS
	1

	 
	Section 101.
	Definitions.
	1

	ARTICLE II
	ESTABLISHMENT OF THE 2.95% SENIOR NOTES
	2

	 
	Section 201.
	Establishment and Designation of the 2.95% Senior Notes
	2

	 
	Section 202.
	Form of the 2.95% Senior Notes
	3

	 
	Section 203.
	Minimum Denomination
	3

	 
	Section 204.
	Principal Amount of the 2.95% Senior Notes
	3

	 
	Section 205.
	Interest Rates; Stated Maturity of the 2.95% Senior Notes
	3

	 
	Section 206.
	No Sinking Fund
	3

	 
	Section 207.
	Time for Payment
	3

	 
	Section 208.
	Paying Agent and Security Registrar.
	3

	 
	Section 209.
	Global Securities; Initial Depositary for Global Securities; Legend
	3

	 
	Section 210.
	Regular Record Date
	4

	 
	Section 211.
	Other Terms of the 2.95% Senior Notes
	4

	ARTICLE III
	Optional Redemption by the Corporation
	4

	 
	Section 301.
	Optional Redemption
	4

	 
	Section 302.
	Calculation of Redemption Price.
	5

	 
	Section 303.
	Notice of Redemption
	5

	ARTICLE IV
	MISCELLANEOUS
	5

	 
	Section 401.
	Application of Second Supplemental Indenture
	5

	 
	Section 402.
	Effective Date of Second Supplemental Indenture
	5

	 
	Section 403.
	Counterparts.
	5

	 
	Section 404.
	No Trustee Representations
	6

	EXHIBIT A
	 
	 

    

i

SECOND SUPPLEMENTAL INDENTURE, dated as of March 9, 2016 (this “Second Supplemental Indenture”), by and between EDISON INTERNATIONAL, a corporation duly organized and existing under the laws of the State of California (the “Corporation” or the “Issuer”), and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., a national banking association, as Trustee under the Base Indenture (as hereinafter defined) (the “Trustee”).
RECITALS OF THE CORPORATION
A.    The Corporation and the Trustee are parties to that certain Senior Indenture, dated as of September 10, 2010 (the “Base Indenture”) providing for the issuance by the Corporation of an unlimited number of series of Securities (as defined in the Base Indenture) from time to time.
B.    Under the Base Indenture, the Corporation is authorized to establish one or more series of Securities at any time in accordance with and subject to the provisions of the Base Indenture, and the terms of such series of Securities may be described by a supplemental indenture executed by the Corporation and the Trustee.
C.    The execution and delivery of this Second Supplemental Indenture has been authorized by a Board Resolution (as defined in the Base Indenture).
D.    Concurrent with the execution hereof, the Corporation has caused its counsel to deliver to the Trustee an Opinion of Counsel (as defined in the Base Indenture) pursuant to Section 102 of the Base Indenture.
E.    The Corporation has done all things necessary to make this Second Supplemental Indenture a legal, valid and binding agreement of the Corporation, in accordance with its terms.
NOW, THEREFORE, the Corporation and the Trustee agree, for the benefit of each other and for the equal and proportionate benefit of Holders of the 2.95% Senior Notes (as defined below) with respect to all provisions herein applicable to such series of notes, as follows:
ARTICLE I
DEFINITIONS
Section 101.    Definitions. 
Unless the context otherwise requires, capitalized terms used but not defined herein have the meaning set forth in the Base Indenture. The following additional terms are hereby established for purposes of this Second Supplemental Indenture and shall have the meanings set forth in this Second Supplemental Indenture only for purposes of this Second Supplemental Indenture:

1

“2.95% Senior Notes” has the meaning specified in Section 201.
“Adjusted Treasury Rate” means, for any Redemption Date, the rate per year equal to the semi-annual equivalent yield to maturity of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Comparable Treasury Price for the Redemption Date.

“Comparable Treasury Issue” means the United States Treasury security or securities selected by an Independent Investment Banker as having an actual or interpolated maturity comparable to the remaining term to stated maturity of the 2.95% Senior Notes to be redeemed that would be utilized, at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate debt securities of comparable maturity to the remaining term of such 2.95% Senior Notes.

“Comparable Treasury Price” means, for any Redemption Date, the average of the Reference Treasury Dealer Quotations for such Redemption Date, or if only one Reference Treasury Dealer quotation is received, such quotation.

“Independent Investment Banker” means Citigroup Global Markets Inc. or its successor or, if such firm or its successor, as applicable, is unwilling or unable to select the Comparable Treasury Issue, one of the remaining Reference Treasury Dealers appointed by us.

“Maturity Date” has the meaning specified in Section 205.

“Redemption Price” has the meaning set forth in Section 301 hereto.

“Reference Treasury Dealer” means (1) Barclays Capital, Inc., Citigroup Global Markets Inc., or U.S. Bancorp Investments, Inc., and any other primary U.S. Government securities dealer in the United States of America (a “Primary Treasury Dealer”) designated by, and not affiliated with, any of the foregoing or their successors, provided, however, that if any of the foregoing, or any of their designees, ceases to be a Primary Treasury Dealer, we will appoint another Primary Treasury Dealer as a substitute, and (2) any other Primary Treasury Dealer selected by us.

“Reference Treasury Dealer Quotations” means, for each Reference Treasury Dealer and any Redemption Date, the average, as determined by the Independent Investment Banker, of the bid and asked prices for the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount) quoted in writing to the Independent Investment Banker by the Reference Treasury Dealer at 5:00 p.m. New York City time on the third business day preceding such Redemption Date.

2

The words “herein,” “hereof” and “hereunder” and other words of similar import refer to this Second Supplemental Indenture as a whole and not to any particular Article, Section or other subdivision.
ARTICLE II
ESTABLISHMENT OF THE 2.95% SENIOR NOTES

Section 201.    Establishment and Designation of the 2.95% Senior Notes. 
Pursuant to the terms hereof and Section 301 of the Base Indenture, the Corporation hereby establishes a series of Securities designated as the “2.95% Senior Notes due 2023” (the “2.95% Senior Notes”).  The 2.95% Senior Notes series may be reopened, from time to time, for issuances of additional Securities of such series, and any additional Securities issued and comprising 2.95% Senior Notes shall have identical terms as the 2.95% Senior Notes, except that the issue price, issue date and, in some cases, the first Interest Payment Date may differ.

Section 202.    Form of the 2.95% Senior Notes. 
The 2.95% Senior Notes shall be issued in the form of one or more Global Securities in substantially the form set forth in Exhibit A hereto.
Section 203.    Minimum Denomination. 
The 2.95% Senior Notes shall be issued in denominations of $1,000 and integral multiples thereof.
Section 204.    Principal Amount of the 2.95% Senior Notes. 
The 2.95% Senior Notes shall be issued in an initial aggregate principal amount of $400,000,000.
Section 205.    Interest Rates; Stated Maturity of the 2.95% Senior Notes. 
The 2.95% Senior Notes shall bear interest at the rate of 2.95% per annum and shall have a Stated Maturity of March 15, 2023 (the “Maturity Date”).  Interest on the 2.95% Senior Notes shall be computed on the basis of a 360-day year of twelve 30-day months; provided that for any partial 30-day month interest shall be computed on the basis of the actual number of days over a 30-day month. Interest on the 2.95% Senior Notes shall be payable on each March 15 and September 15, commencing September 15, 2016 (each an “Interest Payment Date”).
Section 206.    No Sinking Fund. 
No sinking fund is provided for the 2.95% Senior Notes.

3

Section 207.    Time for Payment. 
The Corporation shall make payments of principal, premium, if any, and accrued but unpaid interest on the 2.95% Senior Notes by 11:00 a.m., New York City time, on each Interest Payment Date and on the Redemption Date and the Maturity Date, each as applicable.
Section 208.    Paying Agent and Security Registrar. 
The Trustee is hereby appointed as initial Paying Agent and initial Security Registrar for the 2.95% Senior Notes.  The 2.95% Senior Notes shall be payable at the Corporate Trust Office of the Trustee.
Section 209.    Global Securities; Initial Depositary for Global Securities; Legend. 
The 2.95% Senior Notes are to be issuable only as registered securities without coupons.  The 2.95% Senior Notes may be issued in whole or in part in the form of one or more Global Securities.  The initial depositary for any such Global Securities shall be The Depository Trust Company (“DTC”).  For so long as DTC serves as the Depositary with respect to any such Global Securities, such Global Securities authenticated and delivered hereunder shall bear legend in substantially the following form:
UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITARY TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITARY (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITARY), ANY TRANSFER, PLEDGE, OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL, INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.
Section 210.    Regular Record Date. 
With respect to each Interest Payment Date, the Regular Record Date for the 2.95% Senior Notes shall be March 1 or September 1 (whether or not a Business Day), as the case may be, next preceding such Interest Payment Date. 
Section 211.    Other Terms of the 2.95% Senior Notes. 
The other terms of the 2.95% Senior Notes shall be as expressly set forth herein and in Exhibit A.

4

ARTICLE III 
 
OPTIONAL REDEMPTION BY THE CORPORATION
Section 301.    Optional Redemption. 
Subject to the terms and conditions of the Base Indenture, the 2.95% Senior Notes are redeemable at the option of the Corporation in whole or in part at any time at the price set forth below (the “Redemption Price”). 
The Redemption Price for the 2.95% Senior Notes to be redeemed on any Redemption Date prior to January 15, 2023 will be  equal to the greater of the following amounts:
(1)    100% of the principal amount of the 2.95% Senior Notes to be redeemed; or
(2)    the sum of the present values of the remaining scheduled payments of principal and interest on the 2.95% Senior Notes to be redeemed on that Redemption Date (not including any portion of any payments of interest accrued to the redemption date) discounted to the Redemption Date on a semi-annual basis at the Adjusted Treasury Rate plus 20 basis points, as determined by the Independent Investment Banker;
plus, in each case, accrued and unpaid interest on the notes to be redeemed to the Redemption Date.
The Redemption Price for the 2.95% Senior Notes to be redeemed on any Redemption Date on or after January 15, 2023 will be equal to 100% of the principal amount of the 2.95% Senior Notes being redeemed plus accrued and unpaid interest thereon to but excluding the Redemption Date.
Notwithstanding the foregoing, installments of interest on the 2.95% Senior Notes that are due and payable on Interest Payment Dates falling on or prior to a Redemption Date will be payable on the Interest Payment Date to the registered Holders as of the close of business on the relevant Record Date according to the 2.95% Senior Notes and the Base Indenture.  The Redemption Price will be calculated on the basis of a 360-day year consisting of twelve 30-day months.
Section 302.    Calculation of Redemption Price. 
The Company shall calculate the Redemption Price for any redemption of the 2.95% Senior Notes pursuant to Section 301 and notify the Trustee of such Redemption Price before it sends the amount of the Redemption Price to the Trustee or any Paying Agent.

5

Section 303.    Notice of Redemption
Notice of any redemption pursuant to Section 301 shall be given in the manner and at the time set forth in Section 1104 of the Base Indenture; provided, however, that such notice need not state the dollar amount of the Redemption Price if such dollar amount has not been determined pursuant to Section 301 hereof as of the date such notice is being given to the Holders of the 2.95% Senior Notes being redeemed.
ARTICLE IV
MISCELLANEOUS
Section 401.    Application of Second Supplemental Indenture. 
Except as provided herein, each and every term and condition contained in this Second Supplemental Indenture that modifies, amends or supplements the terms and conditions of the Base Indenture shall apply only to 2.95% Senior Notes established hereby and not to any other series of Securities established or to be established under the Base Indenture.  Except as specifically amended and supplemented by, or to the extent inconsistent with, this Second Supplemental Indenture, the Base Indenture shall remain in full force and effect and is hereby ratified and confirmed.
Section 402.    Effective Date of Second Supplemental Indenture. 
This Second Supplemental Indenture shall be effective upon the execution and delivery hereof by each of the parties hereto.
Section 403.    Counterparts. 
This Second Supplemental Indenture may be executed in any number of counterparts, each of which so executed shall be deemed to be an original, but all such counterparts shall together constitute but one and the same instrument.
Section 404.    No Trustee Representations. 
The Trustee makes no representations as to the validity or sufficiency of this Second Supplemental Indenture.  The statements and recitals herein are deemed to be those of the Corporation and not of the Trustee.

6

In witness whereof, the parties hereto have caused this Second Supplemental Indenture to be duly executed as of the day and year first above written.
        

EDISON INTERNATIONAL 
 

 By   /s/ George T. Tabata         
    George T. Tabata         
    Assistant Treasurer
 
 
THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.,  
  as Trustee  
 
 
By   /s/ Julie Hoffman-Ramos         
    Julie Hoffman-Ramos         
    Vice President         

EXHIBIT A
FORM OF 2.95% SENIOR NOTES DUE 2023

[THIS SECURITY IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF A DEPOSITARY OR A NOMINEE THEREOF.  THIS SECURITY MAY NOT BE EXCHANGED IN WHOLE OR IN PART FOR A SECURITY REGISTERED, AND NO TRANSFER OF THIS SECURITY IN WHOLE OR IN PART MAY BE REGISTERED, IN THE NAME OF ANY PERSON OTHER THAN SUCH DEPOSITARY OR A NOMINEE THEREOF, EXCEPT IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE.]
[INSERT THE FOLLOWING LEGEND IF A GLOBAL SECURITY AND THE DEPOSITARY TRUST COMPANY SERVES AS THE DEPOSITARY WITH RESPECT TO THE GLOBAL SECURITY: UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITARY TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITARY (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITARY), ANY TRANSFER, PLEDGE, OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL, INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.]

EDISON INTERNATIONAL
2.95% SENIOR NOTES DUE 2023
	
		
	No. _________
	$ __________ 
CUSIP No. 281020AJ6

Edison International, a corporation duly organized and existing under the laws of the State of California (herein called the “Corporation,” which term includes any successor Person under the Indenture hereinafter referred to), for value received, hereby promises to pay to____________________, or registered assigns, the principal sum of ___________________ ($__________) onMarch 15, 2023, and to pay accrued but unpaid interest thereon on each March 15 and September 15 (commencing September 15, 2016) (each, an “Interest Payment Date”).  Interest shall accrue from the most recent Interest Payment Date to which interest has been paid or duly provided for, or if no interest has been paid from March 9, 2016 to but excluding the Interest Payment Date or other date of payment for which accrued interest is paid, at the rate of 

A-1

2.95% per annum, until the principal hereof is paid or made available for payment.  Interest on the Security shall be computed on the basis of a 360-day year of twelve 30-day months provided that for any partial 30-day month interest shall be computed on the basis of the actual number of days over a 30-day month.  The interest so payable, and punctually paid or duly provided for, on any Interest Payment Date will, as provided in such Indenture, be paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered at the close of business on the Regular Record Date for such interest, which shall be March 1 or September 1 (whether or not a Business Day), as the case may be, next preceding such Interest Payment Date.  Any such interest not so punctually paid or duly provided for will forthwith cease to be payable to the Holder on such Regular Record Date and may either be paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered at the close of business on a Special Record Date for the payment of such Defaulted Interest to be fixed by the Trustee, notice whereof shall be given to Holders of Securities of this series not less than 10 days prior to such Special Record Date, or be paid at any time in any other lawful manner not inconsistent with the requirements of any securities exchange on which the Securities of this series may be listed, and upon such notice as may be required by such exchange, all as more fully provided in said Indenture.
Payment of the principal of (and premium, if any) and any such interest on this Security will be made at the office or agency of the Corporation maintained for that purpose, in such coin or currency of the United States of America as at the time of payment is legal tender for payment of public and private debts; provided, however, that at the option of the Corporation payment of interest may be made by check mailed to the address of the Person entitled thereto as such address shall appear in the Security Register or by wire transfer at such place and to such account at a banking institution in the United States as may be designated in writing to the Trustee at least sixteen (16) days prior to the date for payment by the Person entitled thereto.
Reference is hereby made to the further provisions of this Security set forth on the reverse hereof, which further provisions shall for all purposes have the same effect as if set forth at this place.
Unless the certificate of authentication hereon has been executed by the Trustee referred to on the reverse hereof by manual signature, this Security shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose.
IN WITNESS WHEREOF, the Corporation has caused this instrument to be duly executed.
EDISON INTERNATIONAL  
 
 
        By         
 
Attest: 

___________________________________

A-2

TRUSTEE’S CERTIFICATE OF AUTHENTICATION
This is one of the Securities of the series designated therein referred to in the within-mentioned Indenture.
The Bank of New York Mellon Trust Company, N.A., 
 
        As Trustee 
 
        By:         
            Authorized Signatory
Dated:  _________________

A-3

Form of Reverse of Security

This Security is one of a duly authorized issue of securities of the Corporation (herein called the “Securities”), issued and to be issued in one or more series under a Senior Indenture, dated as of September 10, 2010 (herein called the “Indenture,” which term shall have the meaning assigned to it in such instrument and shall include the Second Supplemental Indenture, dated as of March 9, 2016), between the Corporation and The Bank of New York Mellon Trust Company, N.A., as Trustee (herein called the “Trustee,” which term includes any successor trustee under the Indenture), and reference is hereby made to the Indenture for a statement of the respective rights, limitation of rights, duties and immunities thereunder of the Corporation, the Trustee and the Holders of the Securities and of the terms upon which the Securities are, and are to be, authenticated and delivered.  This Security is one of the series designated on the face hereof.
Subject to the terms and conditions of the Indenture, the Securities are redeemable at the option of the Corporation (“Optional Redemption”), in whole or in part at any time at the price set forth below (the “Redemption Price”).
The Redemption Price for the 2.95% Senior Notes to be redeemed on any Redemption Date prior to January 15, 2023 will be equal to the greater of the following amounts:
(1)    100% of the principal amount of the 2.95% Securities to be redeemed; or
     (2)    the sum of the present values of the remaining scheduled payments of principal and interest on the 2.95% Senior Notes to be redeemed on that Redemption Date (not including any portion of any payments of interest accrued to the redemption date) discounted to the Redemption Date on a semi-annual basis at the Adjusted Treasury Rate plus 20 basis points, as determined by the Independent Investment Banker;

plus, in each case, accrued and unpaid interest on the notes to be redeemed to the Redemption Date.  

The Redemption Price for the 2.95% Senior Notes to be redeemed on any Redemption Date on or after January 15, 2023 will be equal to 100% of the principal amount of the 2.95% Senior Notes being redeemed plus accrued and unpaid interest thereon to but excluding the Redemption Date.
Notwithstanding the foregoing, installments of interest on the Securities that are due and payable on Interest Payment Dates falling on or prior to a Redemption Date will be payable on the Interest Payment Date to the registered Holders as of the close of business on the relevant Record Date according to the Securities and the Indenture.  The Redemption Price will be calculated on the basis of a 360-day year consisting of twelve 30-day months.

A-4

In the case of an Optional Redemption, notice of redemption will be in writing and mailed first-class postage-prepaid not less than 30 days nor more than 60 days prior to the Redemption Date to each Holder of the Securities to be redeemed at the Holder’s
registered address; provided, however, that such notice need not state the dollar amount of the Redemption Price if such dollar amount has not been determined as of the date such notice is being given to the Holders of the Securities being redeemed.  If money sufficient to pay the Redemption Price of all the Securities (or portions thereof) to be redeemed on the Redemption Date is deposited with the Paying Agent or the Trustee on or prior to the Redemption Date, from and after such Redemption Date such Securities or portions thereof shall cease to bear interest.
Securities in denominations larger than $1,000 in principal amount may be redeemed in part but only in integral multiples of $1,000.
In the event of redemption of this Security in part only, a new Security or Securities of this series and of like tenor for the unredeemed portion hereof will be issued in the name of the Holder hereof upon the cancellation hereof.
The Indenture contains provisions for defeasance at any time of the entire indebtedness of this Security or certain restrictive covenants and Events of Default with respect to this Security, in each case, upon compliance with certain conditions set forth in the Indenture.
If an Event of Default with respect to Securities of this series shall occur and be continuing, the principal of the Securities of this series may be declared due and payable in the manner and with the effect provided in the Indenture.
The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the Corporation and the rights of the Holders of the securities of all series affected under the Indenture at any time by the Corporation and the Trustee with the consent of the Holders of a majority in principal amount of the securities of all series at the time Outstanding affected thereby (voting as one class).  The Indenture contains provisions permitting the Holders of not less than a majority in principal amount of the securities of all series at the time Outstanding with respect to which a default under the Indenture shall have occurred and be continuing (voting as one class), on behalf of the Holders of the securities of all such series, to waive, with certain exceptions, such past default with respect to all such series and its consequences.  The Indenture also permits the Holders of not less than a majority in principal amount of the securities of each series at the time Outstanding, on behalf of the Holders of all securities of such series, to waive compliance by the Corporation with certain provisions of the Indenture.  Any such consent or waiver by the Holder of this Security shall be conclusive and binding upon such Holder and upon all future Holders of this Security and of any Security issued upon the registration of transfer hereof or in exchange therefor or in lieu hereof, whether or not notation of such consent or waiver is made upon this Security.
As provided in and subject to the provisions of the Indenture, the Holder of this Security shall not have the right to institute any proceeding with respect to the Indenture or for the appointment of a receiver or trustee or for any other remedy thereunder unless such Holder shall have previously given the Trustee written notice of a continuing Event of Default with respect to 

A-5

the Securities of this series, the Holders of not less than 33% in principal amount of the Securities of this series at the time Outstanding shall have made written request to the Trustee to institute proceedings in respect of such Event of Default as Trustee and offered the Trustee indemnity satisfactory to it, and the Trustee shall not have received from the Holders of a majority in principal amount of Securities of this series at the time Outstanding a direction inconsistent with such request, and shall have failed to institute any such proceeding, for 60 days after receipt of such notice, request and offer of indemnity.  The foregoing shall not apply to any suit instituted by the Holder of this Security for the enforcement of any payment of principal hereof or any premium or interest hereon on or after the respective due dates expressed herein.
No reference herein to the Indenture and no provision of this Security or of the Indenture shall alter or impair the obligation of the Corporation, which is absolute and unconditional, to pay the principal of and any premium and interest on this Security at the times, place and rate, and in the coin or currency, herein prescribed.
As provided in the Indenture and subject to certain limitations therein set forth, the transfer of this Security is registrable in the Security Register, upon surrender of this Security for registration of transfer at the office or agency of the Corporation in any place where the principal of and any premium and interest on this Security are payable, duly endorsed by, or accompanied by a written instrument of transfer in form satisfactory to the Corporation and the Security Registrar duly executed by, the Holder hereof or his attorney duly authorized in writing, and thereupon one or more new Securities of this series and of like tenor, of authorized denominations and for the same aggregate principal amount, will be issued to the designated transferee or transferees.
The Securities of this series are issuable only in registered form without coupons in denominations of $1,000 and any integral multiple thereof.  As provided in the Indenture and subject to certain limitations therein set forth, Securities of this series are exchangeable for a like aggregate principal amount of Securities of this series and of like tenor of a different authorized denomination, as requested by the Holder surrendering the same.
No service charge shall be made for any such registration of transfer or exchange, but the Corporation may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith.
Prior to due presentment of this Security for registration of transfer, the Corporation, the Trustee and any agent of the Corporation or the Trustee may treat the Person in whose name this Security is registered as the owner hereof for all purposes, whether or not this Security be overdue, and neither the Corporation, the Trustee nor any such agent shall be affected by notice to the contrary.
All terms used in this Security which are defined in the Indenture shall have the meanings assigned to them in the Indenture.
The Indenture and the Securities issued thereby shall be governed by and construed in accordance with the laws of the State of New York.

A-6

ASSIGNMENT FORM
     To assign this Security, fill in the form below: (I) or (we) assign and transfer this Security to
 
                                                    
(Insert assignee’s soc. sec. or tax I.D. no.)
 
 
 
  (Print or type assignee’s name, address and zip code)
                                                    
and irrevocably appoint 
to transfer this Security on the books of the Corporation. The agent may substitute another to act for him.
 
                                                    
Date:                     
Your signature:                                         
(Sign exactly as your name appears on the face of this Senior
 Note)
Tax Identification No.:                                         
SIGNATURE GUARANTEE:

                            
Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of the Security Registrar, which requirements include membership or participation in the Securities Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the Security Registrar in addition to, or in substitution for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended.

A-7EX-10.1

February 29, 2016

Joe Guido

135 Santa Paula Avenue,

San Francisco, CA 94127

Dear Joe:

In connection with your voluntary resignation from employment yesterday, this letter (the
“Agreement”) confirms the agreement between you and Hansen Medical, Inc. (the “Company”) regarding
your separation of employment from the Company.

1. Termination Date. The termination of your employment with the Company by voluntary
resignation was effective as of February 19, 2016 (the “Termination Date”).

2. Effective Date and Rescission. You have up to 21 days after you received this Agreement to
review it. You are advised to consult an attorney of your own choosing (at your own expense)
before signing this Agreement. Furthermore, you have up to seven days after you signed this
Agreement to revoke it. If you wish to revoke this Agreement after signing it, you may do so by
delivering a letter of revocation to the attention of Human Resources at the Company. If you do
not revoke this Agreement, the eighth day after the date you signed it will be the “Effective
Date,” at which time this Agreement shall become final and binding. Because of the seven-day
revocation period, no part of this Agreement will become effective or enforceable until the
Effective Date.

3. Acknowledgement of Payment of Wages. As of the Termination Date, you acknowledge that the
Company has paid you all of your salary (less all applicable withholding taxes and other
deductions) earned through the Termination Date, all of your accrued but unused vacation time,
accrued but unused floater days, and reimbursement for your contribution (if any) into the employee
stock purchase plan. Within thirty days of your Termination Date, you agree to submit any
additional expense reimbursement requests to the Company, and the Company will reimburse all such
authorized expenditures that conform to the expense reimbursement policy. You further acknowledge
that the only payments and benefits that you are entitled to receive from the Company in the future
are those specified in this Agreement.

4. COBRA. Your health insurance benefits will continue through February 29, 2016. You will
receive information about your right to continue your group health insurance coverage under the
Consolidated Omnibus Budget Reconciliation Act (“COBRA”) after the Termination Date. In order to
continue your coverage, you must file the required election form.

5. Severance Pay. Although you otherwise would not have been entitled to receive any
severance pay from the Company, if you sign this Agreement and do not revoke it as provided in
paragraph 2 above, the Company will make a lump sum severance payment to you of $68,404.92, less
all applicable withholding taxes, after the Effective Date. This amount is equal to three months
of your current base salary.

6. Release of All Claims. In consideration for the severance benefits set forth in Sections
4 and 5 above, you waive, release and promise never to assert any claims or causes of action,
whether or not now known, against the Company or its predecessors, successors or past or present
subsidiaries, stockholders, directors, officers, employees, consultants, attorneys, agents, assigns
and employee benefit plans with respect to any matter, including (without limitation) any matter
related to your employment with the Company or the termination of that employment, including
(without limitation) claims to attorneys’ fees or costs, claims of wrongful discharge, constructive
discharge, emotional distress, defamation, invasion of privacy, fraud, breach of contract or breach
of the covenant of good faith and fair dealing and any claims of discrimination or harassment based
on sex, age, race, national origin, sexual orientation, disability or any other basis under
Title VII of the Civil Rights Act of 1964, the California Fair Employment and Housing Act, the Age
Discrimination in Employment Act of 1967, the Americans with Disabilities Act and all other laws
and regulations relating to employment. However, this release covers only those claims that arose
prior to the execution of this Agreement. Execution of this Agreement does not bar any claim that
arises thereafter, including (without limitation) a claim for breach of this Agreement.

7. Waiver. You expressly waive and release any and all rights and benefits under Section 1542
of the California Civil Code (or any analogous law of any other state), which reads as follows:

“A general release does not extend to claims which the creditor does not know or
suspect to exist in his or her favor at the time of executing the release, which if
known by him or her must have materially affected his or her settlement with the
debtor.”

8. Covenant Not to Sue. To the fullest extent permitted by law, at no time subsequent to the
Effective Date will you pursue, or cause or knowingly permit the prosecution, in any state, federal
or foreign court, or before any local, state, federal or foreign administrative agency, or any
other tribunal, any charge, claim or action of any kind, nature and character whatsoever, known or
unknown, which you may now have, have ever had, or may in the future have against Releases, which
is based in whole or in part on any matter released by this Agreement. Nothing in this section
shall prohibit you from filing a charge or complaint with a government agency where, as a matter of
law, the parties may not restrict your ability to file such administrative complaints. However,
you understand and agree that, by entering into this Agreement, you are releasing any and all
individual claims for relief. Nothing in this section shall prohibit or impair you or the Company
from complying with all applicable laws, nor shall this Agreement be construed to obligate either
party to commit (or aid or abet in the commission of) any unlawful act.

9. Other Agreements. At all times in the future, you will remain bound by your Proprietary
Information and Inventions Agreement with the Company that you signed on March 19, 2012, a copy of
which is attached as Exhibit A, as well as the 2006 Equity Incentive Plan and any option award
agreements, exercise notices, vesting requirements, and terms and conditions relating thereto. Per
the terms of that Plan and those agreements, all outstanding equity-based compensation awards that
are unvested as of the Termination Date, including all unvested stock options, restricted stock
units and performance stock unit awards, shall terminate as of the Termination Date without any
payment with respect thereto, and all outstanding stock options that are vested as of the
Termination Date shall remain exercisable in accordance with the terms of the applicable option
award agreement. Except as expressly provided above or elsewhere in this Agreement, this Agreement
renders null and void all prior agreements between you and the Company and constitutes the entire
agreement between you and the Company regarding the subject matter of this Agreement. This
Agreement may be modified only in a written document signed by you and a duly authorized officer of
the Company.

10. Company Property. You represent that you have returned to the Company all property that
belongs to the Company, including (without limitation) copies of documents that belong to the
Company and files stored on your computer(s) that contain information belonging to the Company.

11. No Admission. Nothing contained in this Agreement will constitute or be treated as an
admission by you or the Company of liability, any wrongdoing or any violation of law.

12. Non-disparagement. You and the Company agree that neither party will ever make any
negative or disparaging statements (orally or in writing) about the other (and with respect to the
Company, this includes statements about the Company, its stockholders, directors, officers,
employees, products, services or business practices), except as required by law. Nothing contained
in this paragraph or any other provision of this Agreement shall prevent either party from i)
testifying truthfully before any court, agency, or body, or reporting possible violations of law or
regulation to any governmental regulatory agency or regulatory body, or ii) engaging in concerted
activity protected by the National Labor Relations Act or other applicable law or regulation.

13. Confidentiality of Agreement. You agree that you will not disclose to others the
existence or terms of this Agreement, except that you may disclose such information to taxing
authorities, or to your spouse, attorney or tax adviser if such individuals agree that they will
not disclose to others the existence or terms of this Agreement.

14. Severability. If any term of this Agreement is held to be invalid, void or unenforceable,
the remainder of this Agreement will remain in full and effect and will in no way be affected, and
the parties will use their best efforts to find an alternate way to achieve the same result.

15. Choice of Law. This Agreement will be construed and interpreted in accordance with the
laws of the State of California (other than their choice-of-law provisions).

16. Execution. This Agreement may be executed in counterparts, each of which will be
considered an original, but all of which together will constitute one agreement. Execution of a
facsimile copy will have the same force and effect as execution of an original, and a facsimile
signature will be deemed an original and valid signature.

Please indicate your agreement with the above terms by signing below.

Very truly yours,

HANSEN MEDICAL, INC.

By: /s/ Cary G. Vance

Name: Cary G. Vance

Title: President & Chief Executive Officer

I agree to the terms of this Agreement, and I am voluntarily signing this release of all
claims. I acknowledge that I have read and understand this Agreement, and I understand that I
cannot pursue any of the claims and rights that I have waived in this Agreement at any time in the
future.

/s/ Joe Guido—

Signature of Joe Guido

Dated: March 1, 2016      

Attachments

Exhibit A: Proprietary Information and Inventions Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00255-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00255-of-00352.parquet"}]]